Or. Admin. Code § 333-008-1785

Current through Register Vol. 63, No. 10, October 1, 2024

Section 333-008-1785 - Inhalable Cannabinoid Product Processing Site Requirements

(1) A processing site may only use a non-cannabis additive in an inhalable cannabinoid product if the non-cannabis additive is accompanied by a list of ingredients from the manufacturer of the non-cannabis additive that:

(a) In a header section, displays the name of the non-cannabis additive and the business name of the manufacturer of the non-cannabis additive;

(b) In clear and legible font, includes a statement that the non-cannabis additive is for use in a product intended for human inhalation;

(c) Accurately identifies all ingredients in the non-cannabis additive; and

(d) For each ingredient of the non-cannabis additive, includes:

(A) A Chemical Abstracts Service Reference Number that specifies the ingredient's isomer and, if applicable, enantiomer; and

(B) The ingredient's concentration range within 20 percentage points.

(2) A processing site may not use a non-cannabis additive in an inhalable cannabinoid product that contains any amount of:

(a) Squalene;

(b) Squalane;

(c) Vitamin E Acetate;

(d) Triglycerides, including but not limited to Medium-Chain Triglyceride (MCT) Oil; or

(e) Propylene Glycol, unless the product is going to be delivered through a metered dose inhaler whose functionality does not require combustion or heated vaporization.

(3) A processing site in possession of an inhalable cannabinoid product with non-cannabis additives must:

(a) Record the item in CTS with the item category of "Inhalable Cannabinoid Product with Non-Cannabis Additives".

(b) In the item's ingredients section of CTS record:

(A) The name of all non-cannabis additives used in the items; and

(B) For each non-cannabis additive used, the business name of the manufacturer of the non-cannabis additive.

(c) The ingredients recorded in CTS under subsection (3)(b) if this rule must match the information that is contained in the header section of the non-cannabis additive's list of ingredients as required under subsection (1)(a) of this rule.

(4) A processing site may not manufacture or process an inhalable cannabinoid product that does not meet the requirements of this rule.

(5) A processing site may not possess, sell, deliver, transfer, transport, purchase, or receive an inhalable cannabinoid product that does not meet the requirements of this rule.

Or. Admin. Code § 333-008-1785

PH 79-2021, adopt filed 11/15/2021, effective 1/1/2022; PH 132-2022, minor correction filed 06/09/2022, effective 6/9/2022

Statutory/Other Authority: ORS 475C.815 & 475C.824

Statutes/Other Implemented: ORS 475C.815 & 475C.824